ArticleJournal of hematology & oncology2022

Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure.

Nicholas J Short et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.